Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Neurosci.

Sec. Neurodevelopment

Volume 19 - 2025 | doi: 10.3389/fnins.2025.1618468

This article is part of the Research TopicOligodendroglia Biology and Pathology: Myelination and BeyondView all 6 articles

Tittle: Oligodendrocytes and Myelination: Pioneering New Frontiers in Cognitive Neuroscience

Provisionally accepted
Ning  ZhangNing Zhang1Rulan  YiRulan Yi1Fuwang  ZhongFuwang Zhong1Yali  LuYali Lu1Wenjia  ChenWenjia Chen1Zhidan  KeZhidan Ke1Yi  ZhangYi Zhang2*Wei  LiWei Li3*Liang  ZhouLiang Zhou1*
  • 1Key Laboratory of Anesthesia and Organ Protection (Zunyi Medical University), Ministry of Education, Zunyi Medical University, Zunyi, Guizhou Province, China
  • 2Department of Anesthesiology, Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, China
  • 3State Key Laboratory of Trauma and Chemical Poisoning, Department of Wound Infection and Drug, Daping Hospital, Army Medical University, Chongqing400042, China., Daping Hospital, Chongqing, China

The final, formatted version of the article will be published soon.

There has been a growing interest in the role of oligodendrocytes (OLs) and the myelin sheaths they form around axons in cognitive function. Historically, OLs were primarily considered to be involved in axonal insulation and signal transmission within the central nervous system. However, an increasing body of research indicates that OLs and myelination are integral to neural circuit formation, the regulation of plasticity, and higher-order cognitive functions. Developmental and functional abnormalities in oligodendrocytes, as well as deficits in myelination, are pathologically associated with diseases characterized by clinical cognitive dysfunction. These abnormalities have significant implications for the development of diagnostic and therapeutic strategies for neurological disorders and for the advancement and innovation of treatment methodologies. Investigations into the impact of oligodendrocytes and myelination on cognitive function offer a novel perspective for understanding the development, plasticity, and pathophysiological mechanisms of the nervous system. Future research endeavors are anticipated to elucidate the complexities of oligodendrocytes (OLs) and myelination, thereby offering renewed prospects for the diagnosis and treatment of neurological disorders. This review provides a systematic examination of contemporary research concerning oligodendrocytes and myelination, covering fundamental mechanisms, their roles in cognitive function, recent clinical advancements, emerging therapeutic strategies, ongoing scientific debates, key challenges, and future directions.By incorporating multidisciplinary perspectives, this synthesis seeks to establish a comprehensive framework that will guide subsequent investigations in this domain.The central nervous system (CNS) is composed of complex neural networks, within which glial cell populations function as essential supportive components. These populations are primarily comprised of three distinct cell types: microglia, astrocytes, and oligodendrocytes (OLs) [1] . Remarkably, glial cells are numerically predominant in the CNS, constituting up to 90% of the total cellular population in neural tissue [2] . While traditional neuroscience research has predominantly concentrated on neurons and their synaptic plasticity mechanisms, recent evidence indicates that glial cell populations

Keywords: oligodendrocytes, myelin, demyelination, remyelination, Cognitive Function

Received: 26 Apr 2025; Accepted: 12 Jun 2025.

Copyright: © 2025 Zhang, Yi, Zhong, Lu, Chen, Ke, Zhang, Li and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yi Zhang, Department of Anesthesiology, Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, China
Wei Li, State Key Laboratory of Trauma and Chemical Poisoning, Department of Wound Infection and Drug, Daping Hospital, Army Medical University, Chongqing400042, China., Daping Hospital, Chongqing, 400042, China
Liang Zhou, Key Laboratory of Anesthesia and Organ Protection (Zunyi Medical University), Ministry of Education, Zunyi Medical University, Zunyi, 563000, Guizhou Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.